HARBIN, China, May 15, 2012 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its financial results for the quarter ended March 31, 2012.
Financial Highlights for the Quarter Ended March 31, 2012
Ms. Lianyun Han, CEO of Nutrastar, commented, "We are pleased with our performance in the first quarter, ending it with improved sales across all of our product lines, a strong bottom line and a very robust balance sheet. Demand grew across all of our premium consumer product lines. Sales of Cordyceps increased 7.4%, beverages grew 271.5% and organic and specialty foods rose 13.4%, as over the comparable 2011 period. As expected, we saw a slight decline in the gross margin to 74.1% from 76.4% in the first quarter of 2011 due to an increase in sales from our beverage products which have a higher cost of production than our other consumer products."
Ms. Han continued, "Throughout Q1, we made progress further broadening our market presence via marketing initiatives, and expanding our production capacity. We also made headway growing our premium consumer product portfolio with the upcoming addition of a new Cordyceps instant soluble drink powder and an infused alcohol product. We expect to see revenue from these products upon their introduction to the market and are very excited about the potential opportunities these products will afford us and our shareholders down the road."
As for Q2 and remainder of 2012, Ms. Han stated, "Expansion in both capacity and product offering is expected to stay on track and at the forefront of our operational and business development initiatives." Ms. Han added, "We look forward to launching new premium products to the market which we expect, like our entire existing product lines, will be well received within China's growing mass consumer market."
Financial Position as of March 31, 2012
The Company had cash and cash equivalents totaling $57.00 million or $3.45 per diluted share, total assets of approximately $78.51 million or $4.75 per diluted share, working capital of $55.86 million or $3.38 per diluted share, and stockholders' equity of $75.28 million. Net cash generated from operating activities during the quarter ended March 31, 2012 was $2.39 million.
Outlook for the Year Ending December 31, 2012
Based on management's current expectations, it is believed that revenue will be in the range of $40 million to $44 million, representing an approximate top line increase of 17% to 29% year over year.
For more information regarding Nutrastar's financial performance during the quarter ended March 31, 2012, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on or about May 15, 2012. Management is available to discuss the financial results with investors should they have any questions. To arrange a call with the management team, please contact Investor Relations at 305-918-7000.
About Nutrastar International Inc.
Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 332 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com
Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts
Safe Harbor Statement
This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Howard Gostfrand
American Capital Ventures
Tel: +1-305-918-7000
Email: info@amcapventures.com
NUTRASTAR INTERNATIONAL INC. and subsidiaries | ||||||
For the Three Months Ended March 31, | ||||||
2012 | 2011 | |||||
NET REVENUE | $ | 6,861,018 | $ | 5,796,242 | ||
Cost of goods sold | (1,778,568) | (1,369,800) | ||||
GROSS PROFIT | 5,082,450 | 4,426,442 | ||||
Selling expenses | (382,358) | (409,873) | ||||
General and administrative expenses | (664,705) | (521,326) | ||||
Income from operations | 4,035,387 | 3,495,243 | ||||
Other income (expenses): | ||||||
Interest income | 67,218 | 39,829 | ||||
Foreign exchange differences | 2,404 | 22,921 | ||||
Change in fair value of warrants | (4,029) | 392,191 | ||||
Total other income (expenses) | 65,593 | 454,941 | ||||
Income before income taxes | 4,100,980 | 3,950,184 | ||||
Provision for income taxes | (1,151,402) | (942,413) | ||||
NET INCOME | 2,949,578 | 3,007,771 | ||||
OTHER COMPREHENSIVE INCOME: | ||||||
Foreign currency translation adjustments | 79,753 | 512,009 | ||||
COMPREHENSIVE INCOME | $ | 3,029,331 | $ | 3,519,780 | ||
Earnings per share | ||||||
Basic | $ | 0.19 | $ | 0.20 | ||
Diluted | $ | 0.18 | $ | 0.18 | ||
Weighted average number of shares outstanding | ||||||
Basic | 15,361,458 | 14,513,470 | ||||
Diluted | 16,512,858 | 16,274,183 | ||||
NUTRASTAR INTERNATIONAL INC. and subsidiaries | ||||||
March 31, | December 31, | |||||
2012 | 2011 | |||||
(Unaudited) | ||||||
ASSETS | ||||||
CURRENT ASSETS | ||||||
Cash and cash equivalents | $ | 56,996,050 | $ | 54,556,329 | ||
Restricted cash | - | 4,170 | ||||
Accounts receivable | 90,530 | 82,516 | ||||
Inventories | 1,331,661 | 898,871 | ||||
Prepayments and other receivables | 677,853 | 1,194,466 | ||||
Total current assets | 59,096,094 | 56,736,352 | ||||
OTHER ASSETS | ||||||
Intangible assets, net | 1,907,500 | 2,024,593 | ||||
Property, plant and equipment, net | 12,217,888 | 12,395,567 | ||||
Construction in process | 5,293,097 | 5,271,609 | ||||
Total assets | $ | 78,514,579 | $ | 76,428,121 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
CURRENT LIABILITIES | ||||||
Accounts payable | $ | - | $ | 6,339 | ||
Other payables and accruals | 1,113,875 | 1,064,045 | ||||
Taxes payable | 1,493,787 | 2,585,738 | ||||
Due to a related party | 80,723 | 80,648 | ||||
Preferred stock dividend payable | 396,683 | 529,851 | ||||
Warrants liabilities | 148,440 | 144,411 | ||||
Total current liabilities | 3,233,508 | 4,411,032 | ||||
Total liabilities | 3,233,508 | 4,411,032 | ||||
COMMITMENTS AND CONTINGENCIES (Note 19) | ||||||
STOCKHOLDERS' EQUITY | ||||||
Preferred Stock, $0.001 par value, (1,000,000 shares authorized, | ||||||
113,620 shares and 147,820 shares issued and outstanding, respectively; | ||||||
aggregate liquidation preference amount: $3,181,360 and $4,138,960, | ||||||
plus accrued but unpaid dividend of $396,683 and $529,851, | 2,591,236 | 3,371,206 | ||||
at March 31, 2012 and December 31, 2011, respectively) | ||||||
Common stock, $0.001 par value, 190,000,000 shares authorized | ||||||
15,400,511 shares issued and 15,395,850 shares outstanding at | 15,401 | 14,963 | ||||
March 31, 2012; 14,962,631 shares issued and 14,957,970 shares outstanding at December 31, 2011 | ||||||
Additional paid-in capital | 18,259,607 | 17,180,280 | ||||
Treasury stock, at cost, 4,661 shares of common stock as of March 31, 2012 | ||||||
and December 31, 2011 | (9,553) | (9,553) | ||||
Statutory reserves | 3,407,481 | 3,076,552 | ||||
Retained earnings | 45,720,579 | 43,167,074 | ||||
Accumulated other comprehensive income | 5,296,320 | 5,216,567 | ||||
Total stockholders' equity | 75,281,071 | 72,017,089 | ||||
Total liabilities and stockholders' equity | $ | 78,514,579 | $ | 76,428,121 | ||
NUTRASTAR INTERNATIONAL INC. and subsidiaries | ||||||
For the Three Months Ended March 31, | ||||||
2012 | 2011 | |||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net income | $ | 2,949,578 | $ | 3,007,771 | ||
Adjustments to reconcile net income to cash provided by operating activities: | ||||||
Change in fair value of warrants | 4,029 | (392,191) | ||||
Depreciation and amortization | 309,252 | 263,838 | ||||
Share-based compensation expense | 101,483 | 92,753 | ||||
(Increase) decrease in assets: | ||||||
Accounts receivable | (7,911) | 144,759 | ||||
Inventories | (430,950) | (40,953) | ||||
Prepayments and other receivables | 516,790 | 230,979 | ||||
Increase (decrease) in liabilities: | ||||||
Accounts payable | (6,332) | 24,756 | ||||
Other payables and accruals | 48,578 | (61,212) | ||||
Taxes payable | (1,092,388) | 552,406 | ||||
Net cash provided by operating activities | 2,392,129 | 3,822,906 | ||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||
Purchase of property, plant and equipment and construction in progress | (15,927) | (1,168) | ||||
Net cash used in investing activities | (15,927) | (1,168) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Decrease in restricted cash | 4,170 | 44,650 | ||||
Net cash provided by financing activities | 4,170 | 44,650 | ||||
Foreign currency translation adjustment | 59,349 | 391,926 | ||||
INCREASE IN CASH AND CASH EQUIVALENTS | 2,439,721 | 4,258,314 | ||||
CASH AND CASH EQUIVALENTS, at the beginning of the period | 54,556,329 | 40,758,848 | ||||
CASH AND CASH EQUIVALENTS, at the end of the period | $ | 56,996,050 | $ | 45,017,162 | ||
NON-CASH TRANSACTIONS | ||||||
Preferred stock and dividend converted into common stock | $ | 978,282 | $ | 673,351 | ||
Share-based payment - IR warrants | - | 22,359 | ||||
Preferred stock dividend payable | 65,144 | 181,181 | ||||
Share-based payment to officers and directors under equity incentive plan | 101,483 | 92,753 | ||||
SUPPLEMENTAL DISCLOSURE INFORMATION | ||||||
Income taxes paid | $ | 1,899,301 | $ | 215,317 | ||
